ArticleScientific reports2020
Analysis of leaf morphology, secondary metabolites and proteins related to the resistance to Tetranychus cinnabarinus in cassava (Manihot esculenta Crantz).
Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 23 citations in OpenAlex.
- Topographic imaging with automatic z-axis correction of Brassica oleracea var. viridis leaves by IR-MALDESI mass spectrometry imaging.Analytical and bioanalytical chemistry · 2025Article
- Article
- Genomic and Expression Analysis of Cassava (Genes · 2024Article
- Plant Secondary Metabolites: The Weapons for Biotic Stress Management.Metabolites · 2023Review
- Identifying Terpenoid Biosynthesis Genes inMolecules (Basel, Switzerland) · 2022Article
- Identification of cassava germplasms resistant to two-spotted spider mite in China: From greenhouse large-scale screening to field validation.Frontiers in plant science · 2022Article
- Overexpression of leucoanthocyanidin reductase or anthocyanidin reductase elevates tannins content and confers cassava resistance to two-spotted spider mite.Frontiers in plant science · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Constitutive resistance of plant can be divided into physical and chemical barriers. Cassava (Manihot esculenta Crantz) is susceptible to mites, especially Tetranychus cinnabarinus. Although significant differences in the resistance to T. cinnabarinus are observed in different cassava cultivars, limited research has been done on the mechanism accounting for the resistance. The aim of this study was to explore the mechanism of resistance to T. cinnabarinus by comparing morphology, secondary metabolites and proteins in different cassava cultivars. The anatomical structure of leaves showed that the cassava cultivar Xinxuan 048 (XX048), which showed a stronger resistance to T. cinnabarinus in both greenhouse testing and three years field evaluation tests (2016-2018), had thicker palisade tissue, spongy tissue, lower epidermis and leaf midrib tissue compared to cultivar Guire 4 (GR4). Greenhouse evaluation demonstrated that originally these cultivars were different, leading to differences in constitutive levels of metabolites. The proteomic analysis of protected leaves in XX048 and GR4 revealed that up-regulated differentially expressed proteins (DEPs) were highly enriched in secondary metabolic pathways, especially in the biosynthesis of flavonoids. This study not only provides a comprehensive data set for overall proteomic changes of leaves in resistant and susceptible cassava, but also sheds light on the morphological characteristics of cassava-mite interaction, secondary metabolite defense responses, and molecular breeding of mite-resistant cassava for effective pest control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.